Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study Source: Eur Respir J 2006; 28: 980-985 Year: 2006
Is 1-year follow-up adequate for adult tuberculosis contacts? Source: Eur Respir J 2015; 45: 1501-1504 Year: 2015
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
Multidrug-resistant tuberculosis: treatment outcome after 18 months of invidualised therapy Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001
Empirical treatment for tuberculosis: survey of cases treated over a period of two years Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002
Immunologic tests in diagnosis of tuberculosis infection in children of different age. Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Tuberculin skin test size and risk of tuberculosis: A 12-year follow-up of contacts of TB cases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003
Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004
Clinical, radiological, and bacteriological features of tuberculosis (TB) in teenagers' initial treatment and outcome Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005
6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in Denmark Source: Eur Respir J 2014; 44: 540-543 Year: 2014
A two-year post-treatment follow-up of multi-drug resistant tuberculosis cases who completed a programmatic MDR-TB management at the lung center of the Philippines – a preliminary report Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005
HIV and tuberculosis co-infection: A 7 year retrospective cohort study Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Reducing loss to follow-up during treatment for drug-resistant tuberculosis Source: Eur Respir J, 53 (1) 1802268; 10.1183/13993003.02268-2018 Year: 2019
Predictors of delayed smear conversion after 2 months of tuberculosis treatment Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
Completion of treatment for latent tuberculosis infection Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011